Following the pathway to Alzheimer’s disease
Crossref DOI link: https://doi.org/10.1038/s41593-018-0085-5
Published Online: 2018-02-23
Published Print: 2018-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jagust, William http://orcid.org/0000-0002-4458-113X
Text and Data Mining valid from 2018-02-23
Article History
First Online: 23 February 2018
Competing interests
: The author serves as a consultant to Novartis, Genentech and Bioclinica.